Seguir
Paul Selzer
Paul Selzer
Senior Investigator, Novartis Institutes for BioMedical Research
Dirección de correo verificada de novartis.com
Título
Citado por
Citado por
Año
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties
P Ertl, B Rohde, P Selzer
Journal of medicinal chemistry 43 (20), 3714-3717, 2000
32142000
The coding of the three-dimensional structure of molecules by molecular transforms and its application to structure-spectra correlations and studies of biological activity
JH Schuur, P Selzer, J Gasteiger
Journal of Chemical Information and Computer Sciences 36 (2), 334-344, 1996
4311996
Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds
P Ertl, S Jelfs, J Mühlbacher, A Schuffenhauer, P Selzer
Journal of medicinal chemistry 49 (15), 4568-4573, 2006
2702006
Library design for fragment based screening
A Schuffenhauer, S Ruedisser, A Marzinzik, W Jahnke, P Selzer, ...
Current topics in medicinal chemistry 5 (8), 751-762, 2005
2612005
Chemical information in 3D space
J Gasteiger, J Sadowski, J Schuur, P Selzer, L Steinhauer, V Steinhauer
Journal of Chemical Information and Computer Sciences 36 (5), 1030-1037, 1996
2451996
Relationships between molecular complexity, biological activity, and structural diversity
A Schuffenhauer, N Brown, P Selzer, P Ertl, E Jacoby
Journal of chemical information and modeling 46 (2), 525-535, 2006
1022006
Estimation of pKa for Druglike Compounds Using Semiempirical and Information-Based Descriptors
S Jelfs, P Ertl, P Selzer
Journal of chemical information and modeling 47 (2), 450-459, 2007
962007
How phenotypic screening influenced drug discovery: lessons from five years of practice
D Haasen, U Schopfer, C Antczak, C Guy, F Fuchs, P Selzer
Assay and drug development technologies 15 (6), 239-246, 2017
872017
Complex molecules: do they add value?
P Selzer, HJ Roth, P Ertl, A Schuffenhauer
Current opinion in chemical biology 9 (3), 310-316, 2005
802005
Linking phenotypes and modes of action through high-content screen fingerprints
F Reisen, A Sauty De Chalon, M Pfeifer, X Zhang, D Gabriel, P Selzer
Assay and drug development technologies 13 (7), 415-427, 2015
762015
The RESOLUTE consortium: unlocking SLC transporters for drug discovery
G Superti-Furga, D Lackner, T Wiedmer, A Ingles-Prieto, B Barbosa, ...
Nature Reviews Drug Discovery, 2020
712020
Biodiversity of small molecules–a new perspective in screening set selection
PM Petrone, AM Wassermann, E Lounkine, P Kutchukian, B Simms, ...
Drug discovery today 18 (13-14), 674-680, 2013
632013
Finding the 3D structure of a molecule in its IR spectrum
J Gasteiger, J Schuur, P Selzer, L Steinhauer, V Steinhauer
Fresenius' journal of analytical chemistry 359 (1), 50-55, 1997
611997
Clustering and rule-based classifications of chemical structures evaluated in the biological activity space
A Schuffenhauer, N Brown, P Ertl, JL Jenkins, P Selzer, J Hamon
Journal of chemical information and modeling 47 (2), 325-336, 2007
552007
Web-based cheminformatics tools deployed via corporate Intranets
P Ertl, P Selzer, J Mühlbacher
Drug Discovery Today: BIOSILICO 2 (5), 201-207, 2004
492004
Benchmarking of multivariate similarity measures for high-content screening fingerprints in phenotypic drug discovery
F Reisen, X Zhang, D Gabriel, P Selzer
Journal of biomolecular screening 18 (10), 1284-1297, 2013
432013
Applications of self-organizing neural networks in virtual screening and diversity selection
P Selzer, P Ertl
Journal of chemical information and modeling 46 (6), 2319-2323, 2006
422006
Rapid access to infrared reference spectra of arbitrary organic compounds: scope and limitations of an approach to the simulation of infrared spectra by neural networks
P Selzer, J Gasteiger, H Thomas, R Salzer
Chemistry–A European Journal 6 (5), 920-927, 2000
392000
Comparison of multivariate data analysis strategies for high-content screening
A Kuemmel, P Selzer, M Beibel, H Gubler, CN Parker, D Gabriel
Journal of biomolecular screening 16 (3), 338-347, 2011
382011
Web-based cheminformatics and molecular property prediction tools supporting drug design and development at Novartis
P Ertl, J Muehlbacher, B Rohde, P Selzer
SAR and QSAR in Environmental Research 14 (5-6), 321-328, 2003
372003
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20